Personalized Response-Driven Surgery and Adjuvant Therapy After Neoadjuvant Ipi & Nivo in Resectable Stage III Melanoma: The PRADO Trial
By
GRACE
FEATURING
Vernon Sondak
By
GRACE
FEATURING
Vernon Sondak
Comments 0
Login to view comments.
Click here to Login
